Výpis publikací

DECKER, Barbora, Tomáš MLČOCH, Anastasie PUSTOVALOVA a Tomáš DOLEŽAL. Novel approach to decision making for orphan drugs. International Journal of Technology Assessment in Health Care. NEW YORK: CAMBRIDGE UNIV PRESS, 2023, roč. 39, č. 1, s. 1-6. ISSN 0266-4623. Dostupné z: https://dx.doi.org/10.1017/S0266462323000053.

DECKER, Barbora, Jan TUZIL, Milan LUKAS, Karin CERNA, Martin BORTLIK, Barbora VELACKOVA, Barbora PILNACKOVA a Tomáš DOLEŽAL. Patient-reported symptoms are a more reliable predictor of the societal burden compared to established physician-reported activity indices in inflammatory bowel disease: a cross-sectional study. Expert Review of Gastroenterology & Hepatology. ABINGDON: TAYLOR & FRANCIS, 2023, roč. 17, č. 1, s. 99-108. ISSN 1747-4124. Dostupné z: https://dx.doi.org/10.1080/17474124.2023.2161047.

TUZIL, Jan, Jan MATEJKA, Mamas A A MAMAS a Tomáš DOLEŽAL. Short-term risk of periprocedural stroke relative to radial vs. femoral access: systematic review, meta-analysis, study sequential analysis and meta-regression of 2,188,047 real-world cardiac catheterizations. EXPERT REVIEW OF CARDIOVASCULAR THERAPY. PHILADELPHIA: TAYLOR & FRANCIS INC, 2023, roč. 21, č. 4, s. 293-304. ISSN 1477-9072. Dostupné z: https://dx.doi.org/10.1080/14779072.2023.2187378.

TUZIL, Jan, Barbora FILKOVA PILNACKOVA, Torquil WATT, Jan JISKRA, Marcela KOUDELKOVÁ, Eva NOVOTNA, Klara TUZILOVA, Tomáš DOLEŽAL a Jana BARTAKOVA. The Impact of Subclinical Hypothyroidism on the Quality of Life During Pregnancy: Mapping 5-Level Version of EQ-5D and ThyPRO-39. Value in health. NEW YORK: ELSEVIER SCIENCE INC, 2023, roč. 26, č. 7, s. 1085-1097. ISSN 1098-3015. Dostupné z: https://dx.doi.org/10.1016/j.jval.2023.02.015.

TURKOVA, Barbora, Jan TUZIL, Barbora PILNACKOVA, Helena DOLEZALOVA, Daniela STROSOVA, Vit PETRU, Ester SEBEROVA a Tomáš DOLEŽAL. Health and economic impact of subcutaneous allergen immunotherapy in patients with pollen-induced allergic rhinoconjunctivitis: real-word evidence from the Czech Republic. IMMUNOTHERAPY. London: FUTURE MEDICINE LTD, 2022, roč. 14, č. 14, s. 1109-1120. ISSN 1750-743X. Dostupné z: https://dx.doi.org/10.2217/imt-2022-0143.

ORNSTOVA, Eva, Jan TUZIL, Katerina CHADIMOVA, Tomas MLCOCH a Tomáš DOLEŽAL. Indirect treatment comparison and cost-minimization analysis of riociguat versus selexipag in patients with pulmonary arterial hypertension. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH. ABINGDON: TAYLOR & FRANCIS LTD, 2022, roč. 22, č. 8, s. 1269-1275. ISSN 1473-7167. Dostupné z: https://dx.doi.org/10.1080/14737167.2022.2126833.

STROSOVA, Daniela, Jan TUZIL, Barbora Velackova TURKOVA VELACKOVA, Barbora PILNACKOVA FILKOVA, Lada LZICAROVA DE SOUZA, Helena DOLEZALOVA, Michaela RASKOVA, Michal DUFEK a Tomáš DOLEŽAL. Relationship between Patient Preferences, Attitudes to Treatment, Adherence, and Quality of Life in New Users of Teriflunomide. Pharmaceuticals. Basel: MDPI, 2022, roč. 15, č. 10, s. 1-12. ISSN 1424-8247. Dostupné z: https://dx.doi.org/10.3390/ph15101248.

TUZIL, Jan, Tomas MLCOCH, Jakub ZAVADA, Michal SVOBODA, Karel PAVELKA a Tomáš DOLEŽAL. Time in remission as an alternative outcome measure for rheumatoid arthritis: a 10-year prospective study of 2618 new users of anti-TNF. RHEUMATOLOGY. OXFORD: OXFORD UNIV PRESS, 2022, roč. 61, č. 6, s. 2295-2306. ISSN 1462-0324. Dostupné z: https://dx.doi.org/10.1093/rheumatology/keab737.

MATEJKA, J., I. VARVAROVSKY, J. TUZIL, Tomáš DOLEŽAL, Martin BOBÁK, J. POSPICHAL, P. GEIER, J. VONDRAK, K. BLAHA, J. MALEK, A. STANKOVA, J. BUJDAK, V. ROZSIVAL, V. NOVOTNY, T. LAZARAK, M. PLIVA, J. ERA a P. VOJTISEK. Accession Site Does Not Influence the Risk of Stroke after Diagnostic Coronary Angiography or Intervention: Results from a Large Prospective Registry. CEREBROVASCULAR DISEASES EXTRA. BASEL: KARGER, 2021, roč. 11, č. 3, s. 122-130. ISSN 1664-5456. Dostupné z: https://dx.doi.org/10.1159/000519539.

MLCOCH, Tomas, Barbora DECKER a Tomáš DOLEŽAL. Cost-Effectiveness Analysis of Parenteral Methotrexate for the Treatment of Crohn's Disease. APPLIED HEALTH ECONOMICS AND HEALTH POLICY. CHAM: SPRINGER INTERNATIONAL PUBLISHING AG, 2021, roč. 19, č. 4, s. 593-604. ISSN 1175-5652. Dostupné z: https://dx.doi.org/10.1007/s40258-020-00628-y.

TUZIL, Jan, Jana BARTAKOVA, Torquil WATT a Tomáš DOLEŽAL. Health-related quality of life in women with autoimmune thyroid disease during pregnancy and postpartum: systematic review including 321,850 pregnancies. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH. ABINGDON: TAYLOR & FRANCIS LTD, 2021, roč. 21, č. 6, s. 1179-1193. ISSN 1473-7167. Dostupné z: https://dx.doi.org/10.1080/14737167.2021.1941882.

TUZIL, J., B. FILKOVA, J. MALINA, J. KERESTES a Tomáš DOLEŽAL. Smoking in women with chronic vaginal discomfort is not associated with decreased abundance of Lactobacillus spp. but promotes Mobiluncus and Gardnerella spp. overgrowth - secondary analysis of trial data including microbiome analysis. ČESKÁ GYNEKOLOGIE. PRAGUE: NAKLADATELSKE STREDISKO C L S J E PURKYNE, 2021, roč. 86, č. 1, s. 22-29. ISSN 1210-7832. Dostupné z: https://dx.doi.org/10.48095/cccg202122.

FIALA, Ondrej, Jindrich FINEK, Alexandr POPRACH, Bohuslav MELICHAR, Jindrich KOPECKY, Milada ZEMANOVA, Katerina KOPECKOVA, Tomas MLCOCH, Tomáš DOLEŽAL, Lenka CAPKOVA a Tomas BUCHLER. Outcomes According to MSKCC Risk Score with Focus on the Intermediate-Risk Group in Metastatic Renal Cell Carcinoma Patients Treated with First-Line Sunitinib: A Retrospective Analysis of 2390 Patients. Cancers. BASEL: MDPI, 2020, roč. 12, č. 4, s. 1-12. ISSN 2072-6694. Dostupné z: https://dx.doi.org/10.3390/cancers12040808.

TUŽIL, Jan, Tomáš MLČOCH, Jitka JIRČÍKOVÁ, Jakub ZÁVADA, Lucie NEKVINDOVÁ, Michal SVOBODA, Michal UHER, Zlatuše KŘÍSTKOVÁ, Jiří VENCOVSKÝ, Karel PAVELKA a Tomáš DOLEŽAL. Short-term response in new users of anti-TNF predicts long-term productivity and non-disability: analysis of Czech ATTRA ankylosing spondylitis biologic registry. Expert Opinion on Biological Therapy. TAYLOR & FRANCIS, 2020, roč. 20, č. 2, s. 183-192. ISSN 1471-2598. Dostupné z: https://dx.doi.org/10.1080/14712598.2020.1694900.

HORAKOVA, D., P. ROCKOVA, J. JIRCIKOVA, Tomáš DOLEŽAL, M. VACHOVA, P. HRADILEK, M. VALIS, J. SUCHA, A. MARTINKOVA, R. AMPAPA, M. GRUNERMELOVA, I. STETKAROVA, Pavel ŠTOURAČ, J. MARES, Michal DUFEK, E. KMETOVA, J. ADAMKOVA a T. HRNCIAROVA. Initiation of first disease-modifying treatment for multiple sclerosis patients in the Czech republic from 2013 to 2016: Data from the national registry ReMuS. MULTIPLE SCLEROSIS AND RELATED DISORDERS. OXFORD: ELSEVIER SCI LTD, 2019, roč. 35, OCT 2019, s. 196-202. ISSN 2211-0348. Dostupné z: https://dx.doi.org/10.1016/j.msard.2019.08.003.

MLCOCH, Tomas, Tereza HRNCIAROVA, Jan TUZIL, Jakub ZADAK, Marisca MARIAN a Tomáš DOLEŽAL. Propensity Score Weighting Using Overlap Weights: A New Method Applied to Regorafenib Clinical Data and a Cost-Effectiveness Analysis. Value in health. NEW YORK: ELSEVIER SCIENCE INC, 2019, roč. 22, č. 12, s. 1370-1377. ISSN 1098-3015. Dostupné z: https://dx.doi.org/10.1016/j.jval.2019.06.010.

DOLEŽAL, Tomáš, Jiří KLIMEŠ a Kateřina KUBÁČKOVÁ. Health-economic aspects of cystic fibrosis screening and therapy. 2014. vyd. ERS, 2014. ISBN 978-1-84984-050-7. Dostupné z: https://dx.doi.org/10.1183/1025448x.10010613.